Actavis Group Ptc And Actavis UK v Boehringer Ingelheim Pharma GmbH and Co. KG: ECJ 12 Mar 2015

ECJ Judgment – Reference for a preliminary ruling – Medicinal products for human use – Regulation (EC) No 469/2009 – Article 3 – Supplementary protection certificate – Conditions for obtaining such a certificate – Medicinal products containing in whole or in part the same active ingredient – Medicinal products placed on the market in succession – Combination of active ingredients – Active ingredient previously marketed in the form of a medicinal product with a single active ingredient – Conditions for obtaining several certificates on the basis of the same patent – Modification of the active ingredients of a basic patent

Judges:

A. O Caoimh, P

Citations:

C-577/13, [2015] EUECJ C-577/13

Links:

Bailii

Statutes:

Regulation (EC) No 469/2009 3

Jurisdiction:

European

Health

Updated: 29 May 2022; Ref: scu.544271